Advertisement

Pituitary

, Volume 12, Issue 3, pp 226–235 | Cite as

Pituitary-gonadal axis: historical notes

  • J. Lindholm
  • E. Husted NielsenEmail author
Article

Abstract

Though it was appreciated at a very early time that removal of gonads had evident consequences, the anatomy and function of the gonads were essentially unknown in the Antiquity. It was not until around 1600 that men like Vesalius, de Graaf and Leeuwenhoek initiated rational studies on the structure and function of the gonads. The close relationship between gonads and hypothalamus/pituitary was recognized less than 100 years ago. The last pituitary hormone with gonadotroph effect was discovered a generation ago. This paper briefly describes some major points in the development of our knowledge of the pituitary-gonadal function. Considering the huge number of studies involved, this review reflects but a tiny fraction of the work laid down over millennia within this field.

Keywords

History of medicine Pituitary Ovary Testis 

References

  1. 1.
    Preus A (1977) Galen’s criticism of Aristotle’s conception theory. J Hist Biol 10:65–85. doi: 10.1007/BF00126095 PubMedCrossRefGoogle Scholar
  2. 2.
    Aristotle (1910) The works of Aristotle. In: Smith JA, Ross WD (eds) Historia animalium, liber IX, 50. Translated by Thompson, D’Arcy W, Clarendon Press, Oxford. Available via http://etext.lib.virginia.edu/modeng/modengA.browse.htm
  3. 3.
    Saunders CM, O’Malley CD (1950) The illustrations from the works of Andreas Vesalius of Brussels: with annotations and translations, a discussion of the plates and their background, authorship and influence, and a biographical sketch of Vesalius. The World Publ. Co, Cleveland & New YorkGoogle Scholar
  4. 4.
    Herrlinger R, Feiner E (1964) Why did Vesalius not discover the Fallopian tubes? Med Hist 8:335–341PubMedGoogle Scholar
  5. 5.
    Jocelyn HD, Setchell BP (1972) Regnier de Graaf on the human reproductive organs: an annotated translation of Tractatus de virorum organis generationi inservientibus (1668) and De mulierum organis generationi inservientibus tractatus novus (1672). J Reprod Fertil Suppl 17:1–222PubMedGoogle Scholar
  6. 6.
    Ankum WM, Houtzager HL, Bleker OP (1996) Reinier de Graaf (1641–1673) and the Fallopian tube. Hum Reprod Update 2:365–369. doi: 10.1093/humupd/2.4.365 PubMedCrossRefGoogle Scholar
  7. 7.
    Prévost JL, Dumas JAB (1824) De la génération dans les Mammifères, et des premiers indices du développement de I’Embryon. Ann Sci Nat 3:113–138Google Scholar
  8. 8.
    von Baer KA 1956[1827] De ovi mammalium et homini genesi. Translation in: on the genesis of the ovum of mammals and of man. A letter to the Imperial Academy of Sciences of St. Petersburg. Isis 47:117–152Google Scholar
  9. 9.
    Newport G (1853) On the impregnation of the ovum in the Amphibia. And on the direct agency of the spermatozoon. Phil Trans R Soc Lond 143:233–290. doi: 10.1098/rstl.1853.0010 CrossRefGoogle Scholar
  10. 10.
    Hegar A (1878) Die Castration der Frauen. In: Volkmann R (ed) Samlung klinischer Vorträge 1875–1880. pp 925–1068Google Scholar
  11. 11.
    Brown-Séquard CE (1890) Remarques sur les effets produits sur la femme par des injections sous-cutanes d’un liquide retiré d’ovaires d’animaux. Arch Physiol Norm Pathol 2:456–457Google Scholar
  12. 12.
    Brown-Séquard CE (1889) Des effets produits chez I’homme par des injections sous-cutanes d’un liquide retiré des testicules frais de cobaye et de chien. C R Seances Soc Biol Fil 1:415–419Google Scholar
  13. 13.
    Brown-Séquard CE (1889) Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 134:105–107. doi: 10.1016/S0140-6736(00)64118-1 CrossRefGoogle Scholar
  14. 14.
    Murray GR (1891) Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. BMJ 2:796–797CrossRefGoogle Scholar
  15. 15.
    Novak E (1924) Ovarian therapy. J Am Med Assoc 83:2016–2018Google Scholar
  16. 16.
    Perone N (1993) The history of steroidal contraceptive development: the progestins. Perspect Biol Med 36:347–362PubMedGoogle Scholar
  17. 17.
    Knauer E (1900) Die Ovarientransplantation. Experimentelle Studie. Arch Gynakol 60:322–376. doi: 10.1007/BF01874236 CrossRefGoogle Scholar
  18. 18.
    Halban J (1900) Ueber den Einfluss der Ovarien auf die Entwicklung des Genitales. Monatsschr Geburtshilfe Gynäkol 12:496–505Google Scholar
  19. 19.
    Iscovesco H (1912) Le lipoide utéro-stimulant de l’ovaire. Propriétés physiologiques. C R Seances Soc Biol Fil 73:104–106Google Scholar
  20. 20.
    Herrmann E (1915) Über eine wirksame Substanz im Eierstocke und in der Placenta. Monatsschr Geburtshilfe Gynäkol 41:1–50Google Scholar
  21. 21.
    Fellner O (1921) Über die Tätigkeit des Ovarium in der Schwangerschaft (Interstitiellen Zellen). Monatsschr Geburtshilfe Gynäkol 54:88–94Google Scholar
  22. 22.
    Corner GW (1965) The early history of oestrogenic hormones. The Sir Henry Dale Lecture for 1964. J Endocrinol 31:iii–xviiPubMedGoogle Scholar
  23. 23.
    Allen E, Doisy EA (1923) An ovarian hormone. J Am Med Assoc 81:819–821Google Scholar
  24. 24.
    Doisy EA, Ralls JO, Allen E, Johnston CG (1924) The extraction and some properties of an ovarian hormone. J Biol Chem 61:711–727Google Scholar
  25. 25.
    Aschheim S, Zondek B (1927) Hypophysenvorderlappen Hormone und Ovarialhormone im Harn von Schwangeren. Klin Wochenschr 6:1322. doi: 10.1007/BF01728562 CrossRefGoogle Scholar
  26. 26.
    Parkes AS (1965) The rise of reproductive endocrinology 1926–1940. J Endocrinol 34:xx–xxxiiGoogle Scholar
  27. 27.
    Sneader W (2000) The discovery of oestrogenic hormones. J Br Menopause Soc 6:129–133. doi: 10.1258/136218000100320977 CrossRefGoogle Scholar
  28. 28.
    Inhoffen HH, Hohlweg W (1938) Neue per os-wirksame weibliche Keimdrüsenhormon-Derivate: I7-Aethinyl-oestradiol und Pregnen-in-on-3-ol-17. Naturwissenschaften 26:96. doi: 10.1007/BF01681040 CrossRefGoogle Scholar
  29. 29.
    Prenant A (1898) La valeur morphologique du corps jaune. Son action physiologique et thérapeutique possible. Rev Gen Sci Pure Appl 9:646–650Google Scholar
  30. 30.
    Magnus V (1901) Ovariets betydning for svangerskabet med særligt henblik til corpus luteum. Norsk Mag Lægevidenskab 62:1138–1145Google Scholar
  31. 31.
    Fraenkel L (1903) Die Funktion des Corpus luteum. Arch Gynakol 68:438–545. doi: 10.1007/BF01669987 CrossRefGoogle Scholar
  32. 32.
    Allen VM (2005) My life with progesterone. Am J Obstet Gynecol 193:575–577. doi: 10.1016/j.ajog.2005.04.034 CrossRefGoogle Scholar
  33. 33.
    Greep RO (1977) The genesis of research on the progestins. Ann N Y Acad Sci 286:1–9. doi: 10.1111/j.1749-6632.1977.tb29401.x PubMedCrossRefGoogle Scholar
  34. 34.
    Short RV (1977) The discovery of the ovaries. In: Zuckerman S, Weir BJ (eds) The ovary, vol 1, 2nd edn. Academic Press, New York, pp 1–39Google Scholar
  35. 35.
    Howards SS (1997) Antoine van Leeuwenhoek and the discovery of sperm. Fertil Steril 67:16–17. doi: 10.1016/S0015-0282(97)81848-1 PubMedCrossRefGoogle Scholar
  36. 36.
    Ruestow EG (1983) Images and ideas: Leeuwenhoek’s perception of the spermatozoa. J Hist Biol 16:185–224. doi: 10.1007/BF00124698 PubMedCrossRefGoogle Scholar
  37. 37.
    Berthold AA (1849) Transplantation of testes. Arch Anat Physiol Wissenschaft Med 42–46. Translation in: Quering DP (1944) Bull Hist Med 16:399–401Google Scholar
  38. 38.
    Jørgensen CB (1971) John Hunter, A. A. Berthold and the origin of endocrinology. Acta Hist Sci Nat Med 24:1–54Google Scholar
  39. 39.
    Leydig F (1850) Zur Anatomie der männlichen Geschlechtsorgane und Analdrüsen bei Säugetiere. Z Wiss Zool 2:1–57Google Scholar
  40. 40.
    Christensen K (2007) A history of Leydig cell research. In: Payne AH, Hardy MP (eds) Contemporary endocrinology, the Leydig cell in health and disease. Humana Press Inc, Totowa, NJ, pp 3–30CrossRefGoogle Scholar
  41. 41.
    Sertoli E (1865) Dell’esistenza di particolari cellule ramificate nei canalicoli seminiferi del testicolo umano. Il Morgagni 7:31–40Google Scholar
  42. 42.
    Reinke F (1896) Beiträge zur Histologie des Menschen. I. Ueber Krystalloidbildungen in den interstitiellen Zellen des menschlichen Hodens. Arch Mikr Anat 47:34–44CrossRefGoogle Scholar
  43. 43.
    Bouin P, Ancel P (1903) Recherches sur les cellules interstitielles du testicule des mammifères. Arch Zool Exp Gén 1(4 serie):437–523Google Scholar
  44. 44.
    Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28:325–353PubMedGoogle Scholar
  45. 45.
    Schäfer EA (1895) Address in physiology on internal secretions. Lancet 146:321–324. doi: 10.1016/S0140-6736(02)06206-2 CrossRefGoogle Scholar
  46. 46.
    Moore CR, Gallagher TF, Koch FC (1929) The effects of extracts of testis in correcting the castrated condition in the fowl and in the mammal. Endocrinology 13:367–374Google Scholar
  47. 47.
    Butenandt A, Hanisch G (1935) Uber Testosterone. Umwandlung des Dehydro-Androsterons in Androstendiol und Testosterone; ein Weg zur Darstellung des Testosterons aus Cholestrin. Z Phys Chem 237:89–97Google Scholar
  48. 48.
    Ruzicka L, Wettstein A (1935) Sexualhormone VII. Uber die kunstliche Herstellung des Testikelhormons. Testosteron (Androsten-3-on-17-ol.). Helv Chim Acta 18:1264–1275. doi: 10.1002/hlca.193501801176 CrossRefGoogle Scholar
  49. 49.
    David K, Dingemanse E, Freud J, Laqueur E (1935) Über krystallinisches mannliches Hormon aus Hoden (Testosteron) wirksamer als aus Harn oder aus Cholesterin bereitetes Androsteron. Z Phys Chem 233:281–282Google Scholar
  50. 50.
    Kochakian CD (1990) History of anabolic-androgenic steroids. In: Lin GC, Erinoff L (eds) Anabolic steroid abuse, Research Monograph 102. Natl Inst Abuse, MD, pp 29–59. Available via www.drugabuse.gov/pdf/monographs/download102.html
  51. 51.
    McCullagh DR (1932) Dual endocrine activity of the testes. Science 76:19–20. doi: 10.1126/science.76.1957.19 PubMedCrossRefGoogle Scholar
  52. 52.
    de Kretser DM, Robertson DM (1989) The isolation and physiology of inhibin and related proteins. Biol Reprod 40:33–47. doi: 10.1095/biolreprod40.1.33 PubMedCrossRefGoogle Scholar
  53. 53.
    Steinberger A, Steinberger E (1976) Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology 99:918–921PubMedGoogle Scholar
  54. 54.
    Ascher B (1912) Ueber die Funktion der Hypophyse. Arch Gesamm Physiol 46:1–46CrossRefGoogle Scholar
  55. 55.
    Frölich A (1901) Ein Fall von Tumor der Hypophysis cerebri ohne Akromegalie. Wien Klin Rundschau 15:883–908Google Scholar
  56. 56.
    Simmond M (1914) Über Hypophysisschwund mit tödlichem Ausgang. Dtsch Med Wochenschr 40:322–323CrossRefGoogle Scholar
  57. 57.
    Zondek B, Aschheim S (1927) Das Hormon des Hypophysenvorderlappens. Klin Wochenschr 6:248–252. doi: 10.1007/BF01710709 CrossRefGoogle Scholar
  58. 58.
    Smith PE, Engle ET (1927) Experimental evidence regarding the rôle of anterior pituitary in development and regulation of genital system. Am J Anat 40:159–217. doi: 10.1002/aja.1000400202 CrossRefGoogle Scholar
  59. 59.
    Zondek B (1930) Über die Hormone des Hypophysenvorderlappens. Klin Wochenschr 9:245–248. doi: 10.1007/BF01765181 CrossRefGoogle Scholar
  60. 60.
    Fevold HL, Hisaw FL (1931) Leonard. The gonad-stimulating and the luteinizing hormones of the anterior lobe of the hypophyesis. Am J Physiol 97:291–301Google Scholar
  61. 61.
    Lunenfeld B (2004) Historical perspectives in gonadotrophin therapy. Hum Reprod Update 10:453–467. doi: 10.1093/humupd/dmh044 PubMedCrossRefGoogle Scholar
  62. 62.
    Seegar-Jones GE, Gey GO, Gey MK (1943) Hormone production by placental cells maintained in continuous culture. Bull Johns Hopkins Hosp 72:26–38Google Scholar
  63. 63.
    Hayden CJ, Balen AH, Rutherford AJ (1999) Recombinant gonadotrophins. Br J Obstet Gynaecol 106:188–196PubMedGoogle Scholar
  64. 64.
    Gemzell CA, Diczfalusy E, Tillinger G (1958) Clinical effect of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol Metab 18:1333–1348PubMedGoogle Scholar
  65. 65.
    Gray CJ (1988) Glycoprotein gonadotropins. Structure and synthesis. Acta Endocrinol Suppl (Copenh) 288:20–27Google Scholar
  66. 66.
    Lindholm J (2006) Growth hormone: historical notes. Pituitary 9:5–10. doi: 10.1007/s11102-006-7557-4 PubMedCrossRefGoogle Scholar
  67. 67.
    Germond M, Dessole S, Senn A, Loumaye E, Howles C, Beltrami V (1992) Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 339:1170. doi: 10.1016/0140-6736(92)90770-4 PubMedCrossRefGoogle Scholar
  68. 68.
    Devroey P, van Steheirteghem A, Mannaerts B, Bennink HC (1992) Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 339:1170–1171. doi: 10.1016/0140-6736(92)90770-4 PubMedCrossRefGoogle Scholar
  69. 69.
    Gaines WL (1915) A contribution to the physiology of lactation. Am J Physiol 38:285–312Google Scholar
  70. 70.
    Stricker P, Grueter F (1928) Action du lobe antérieur de l’hypophyse sur la montée laiteuse. C R Seances Soc Biol Fil 99:1978–1980Google Scholar
  71. 71.
    Riddle O, Bates RW, Dykshorn SW (1932) New hormone of the anterior pituitary. Proc Soc Exp Biol Med 29:1211–1212Google Scholar
  72. 72.
    Riddle O, Bates RW, Dykshorn SW (1933) The preparation, identification and assay of prolactin—a hormone of the anterior pituitary. Am J Physiol 105:191–216Google Scholar
  73. 73.
    Friesen HG (1995) The discovery of human prolactin: a very personal account. Clin Invest Med 18:66–72PubMedGoogle Scholar
  74. 74.
    Peake GT, McKeel DW, Jarett L, Daughaday WH (1969) Ultrastructural, histologic and hormonal characterization of a prolactin-rich human pituitary tumor. J Clin Endocrinol Metab 29:1383–1393PubMedGoogle Scholar
  75. 75.
    Kleinberg DL, Frantz AG (1971) Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest 50:1557–1568. doi: 10.1172/JCI106643 PubMedCrossRefGoogle Scholar
  76. 76.
    Hwang P, Guyda H, Friesen H (1971) A radioimmunoassay for human prolactin. Proc Natl Acad Sci USA 68:1902–1906. doi: 10.1073/pnas.68.8.1902 PubMedCrossRefGoogle Scholar
  77. 77.
    del Pozo E, Friesen H, Burmeister P (1970) Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report. Schweiz Med Wochenschr 103:847–848Google Scholar
  78. 78.
    Lutterbeck PM, Pryor JS, Varga L, Wenner R (1971) Treatment of non-puerperal galactorrhoea with an ergot alkaloid. BMJ 3:228–229PubMedCrossRefGoogle Scholar
  79. 79.
    Varga L, Lutterbeck PM, Pryor JS, Wenner R, Erb H (1972) Suppression of puerperal galactorrhea with an ergot alkaloid: a double-blind study. BMJ 2:743–744PubMedCrossRefGoogle Scholar
  80. 80.
    Heller CG, Heller EJ (1939) Gonadotropic hormone: urine assay of normal cycling, menopausal, castrated, and estrin treated human females. J Clin Invest 18:171–178. doi: 10.1172/JCI101032 PubMedCrossRefGoogle Scholar
  81. 81.
    Biddulph C, Meyer RK, Gumbreck LG (1941) The influence of estriol, estradiol and progesterone on the secretion of gonadotropic hormones in parabiotic rats. Endocrinology 26:280–284CrossRefGoogle Scholar
  82. 82.
    Heller CG, Segaloff A, Nelson WO (1943) Effect of testosterone proprionate on pituitary gonadotropic potency of the castrated male rat. Endocrinology 33:186–188Google Scholar
  83. 83.
    Haberlandt L (1921) Ueber hormonale Sterilisierung des weiblichen Tierkörpers. Munch Med Wochenschr 68:1577–1578Google Scholar
  84. 84.
    Makepeace AW, Weinstein GL, Friedman MH (1937) The effect of progestin and progesterone on ovulation in the rabbit. Am J Physiol 119:512–516Google Scholar
  85. 85.
    Pincus G, Garcia CR, Rock J et al (1959) Effectiveness of an oral contraceptive. Science 130:81–83. doi: 10.1126/science.130.3367.81 PubMedCrossRefGoogle Scholar
  86. 86.
    Reichlin S (1989) TRH: historical aspects. Ann N Y Acad Sci 553:1–6. doi: 10.1111/j.1749-6632.1989.tb46627.x PubMedCrossRefGoogle Scholar
  87. 87.
    Schally AV, Arimura A, Baba Y et al (1971) Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 43:393–399. doi: 10.1016/0006-291X(71)90766-2 PubMedCrossRefGoogle Scholar
  88. 88.
    Amoss M, Burgus R, Blackwell R, Vale W, Fellows R, Guillemin R (1971) Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochem Biophys Res Commun 44:205–210. doi: 10.1016/S0006-291X(71)80179-1 PubMedCrossRefGoogle Scholar
  89. 89.
    Matsuo H, Baba Y, Nair RMG, Arimura A, Schally AV (1971) Structure of the porcine LH- and FSH-releasing hormone: I. The proposed amino acid sequence. Biochem Biophys Res Commun 43:1334–1339. doi: 10.1016/S0006-291X(71)80019-0 PubMedCrossRefGoogle Scholar
  90. 90.
    Midgley SR Jr (1966) Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology 79:10–18PubMedGoogle Scholar
  91. 91.
    Odell WD, Ross GT, Rayford PL (1967) Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest 46:248–255PubMedCrossRefGoogle Scholar
  92. 92.
    Bagshawe KD, Wilde CE, Orr AH (1966) Radioimmunoassay for human chorionic gonadotropin and luteinizing hormone. Lancet 287:1118–1119. doi: 10.1016/S0140-6736(66)91136-6 CrossRefGoogle Scholar
  93. 93.
    Schalch DS, Parlow AF, Boon RC, Reichlin S (1968) Measurement of human luteinizing hormone in plasma by radioimmunoassay. J Clin Invest 47:665–678PubMedGoogle Scholar
  94. 94.
    Odell WD, Parlow AF, Cargille CM, Ross GT (1968) Radioimmunoassay for human follicle-stimulating hormone: physiological studies. J Clin Invest 47:2552–2562Google Scholar
  95. 95.
    Leading article (1984) Pulsatile control of reproduction. Lancet 324:382–383CrossRefGoogle Scholar
  96. 96.
    Belchetz PE, Plant TM, Nakai Y, Keogh EL, Knobil E (1978) Hypophysial response to continous and intermittent delivery of hypothalamic gonadotropin-rleasing hormone. Science 202:631–633. doi: 10.1126/science.100883 PubMedCrossRefGoogle Scholar
  97. 97.
    Crowley WF Jr, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB Jr (1981) Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370–372PubMedGoogle Scholar
  98. 98.
    Engel JB, Schally AV (2007) Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 3:157–167. doi: 10.1038/ncpendmet0399 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Endocrinology, Aalborg HospitalAarhus University HospitalAalborgDenmark

Personalised recommendations